Shultz L D, Schweitzer P A, Rajan T V, Yi T, Ihle J N, Matthews R J, Thomas M L, Beier D R
Jackson Laboratory, Bar Harbor, Maine 04609.
Cell. 1993 Jul 2;73(7):1445-54. doi: 10.1016/0092-8674(93)90369-2.
Mice homozygous for the recessive allelic mutation motheaten (me) or viable motheaten (mev) on chromosome 6 develop severe defects in hematopoiesis. In this paper we present the findings that the me and mev mutations are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. High resolution mapping localized me to an area tightly linked to Hcph on chromosome 6. Abnormalities of the Hcph protein product were demonstrated by Western blot analysis and by activity assays in both me/me and mev/mev mice. Molecular analysis of the Hcph cDNA identified abnormal transcripts in both mutants. DNA sequence analyses of cDNA and genomic clones revealed that both the me and mev mutations are point mutations that result in aberrant splicing of the Hcph transcript. These findings provide the first available animal models for a specific protein-tyrosine phosphatase deficiency, thus facilitating determination of the precise role of this signaling molecule in hematopoiesis.
在6号染色体上携带隐性等位基因突变“食母生”(me)或“存活食母生”(mev)的纯合子小鼠,在造血过程中会出现严重缺陷。在本文中,我们展示了以下研究结果:me和mev突变位于造血细胞蛋白酪氨酸磷酸酶(Hcph)基因内。高分辨率定位将me定位到6号染色体上与Hcph紧密连锁的区域。通过蛋白质免疫印迹分析和活性测定,在me/me和mev/mev小鼠中均证实了Hcph蛋白产物的异常。对Hcph cDNA的分子分析在两个突变体中均鉴定出异常转录本。对cDNA和基因组克隆的DNA序列分析表明,me和mev突变均为点突变,导致Hcph转录本的异常剪接。这些发现为特定蛋白酪氨酸磷酸酶缺乏症提供了首个可用的动物模型,从而有助于确定该信号分子在造血过程中的精确作用。